Literature DB >> 36207416

Identification of the polyether ionophore lenoremycin through a new screening strategy for targeting cancer stem cells.

Hiroaki Ikeda1, Misato Kawami1, Masaya Imoto2, Hideaki Kakeya3.   

Abstract

Targeting and eradicating cancer stem cells (CSCs), also termed tumor-initiating cells, are promising strategies for preventing cancer progression and recurrence. To identify candidate compounds targeting CSCs, we established a new screening strategy with colorectal CSC spheres and non-CSC spheres in three-dimensional (3D) culture system. Through chemical screening using our system with in-house microbial metabolite library, we identified polyether cation ionophores that selectively inhibited CSC sphere formation, whereas CSC spheres were resistant to conventional anticancer agents. One of the hit compounds, the most selective and effective microbial metabolite lenoremycin, decreased CSC populations via inducing reactive oxygen species production. This study demonstrated that our newly established screening system is useful for discovering agents that selectively eliminate CSCs.
© 2022. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.

Entities:  

Keywords:  Cancer stem cells; Polyether ionophore; Reactive oxygen species; Screening

Year:  2022        PMID: 36207416     DOI: 10.1038/s41429-022-00571-1

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   3.424


  33 in total

Review 1.  Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.

Authors:  Naoko Takebe; Lucio Miele; Pamela Jo Harris; Woondong Jeong; Hideaki Bando; Michael Kahn; Sherry X Yang; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2015-04-07       Impact factor: 66.675

Review 2.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

3.  High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing.

Authors:  Xiaojun Yan; Lyu Zhou; Zhaozhao Wu; Xun Wang; Xiuyuan Chen; Fan Yang; Yanan Guo; Min Wu; Yuyang Chen; Wenjing Li; Jun Wang; Yanan Du
Journal:  Biomaterials       Date:  2018-05-16       Impact factor: 12.479

Review 4.  Cancer stem cells revisited.

Authors:  Eduard Batlle; Hans Clevers
Journal:  Nat Med       Date:  2017-10-06       Impact factor: 53.440

5.  Tankyrase Inhibitors Target Colorectal Cancer Stem Cells via AXIN-Dependent Downregulation of c-KIT Tyrosine Kinase.

Authors:  Myung-Kyu Jang; Tetsuo Mashima; Hiroyuki Seimiya
Journal:  Mol Cancer Ther       Date:  2020-01-06       Impact factor: 6.261

Review 6.  Targeting Cancer Stemness in the Clinic: From Hype to Hope.

Authors:  Caner Saygin; Daniela Matei; Ravindra Majeti; Ofer Reizes; Justin D Lathia
Journal:  Cell Stem Cell       Date:  2018-12-27       Impact factor: 24.633

7.  A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.

Authors:  Franck Madoux; Allison Tanner; Michelle Vessels; Lynsey Willetts; Shurong Hou; Louis Scampavia; Timothy P Spicer
Journal:  SLAS Discov       Date:  2017-01-13       Impact factor: 3.341

8.  A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.

Authors:  Madhu Lal-Nag; Lauren McGee; Rajarshi Guha; Ernst Lengyel; Hilary A Kenny; Marc Ferrer
Journal:  SLAS Discov       Date:  2017-01-31       Impact factor: 3.341

9.  21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jun Wang; Yong Dong; Jia-Yuan Sun; Yong-Xiong Chen; Zhen-Yu He
Journal:  Front Oncol       Date:  2019-01-29       Impact factor: 6.244

Review 10.  Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.

Authors:  Hongyi Li; Yang Yang; Weiqi Hong; Mengyuan Huang; Min Wu; Xia Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.